The table below shows Pulse Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$14.60M
-$13.52M
-$9.78M
-$6.57M
-$15.59M
-$11.69M
Capital expenditure
$33.00K
$45.00K
$5.00K
$39.00K
$279.00K
$51.00K
Investing cash flow
-$33.00K
-$45.00K
-$5.00K
-$39.00K
-$279.00K
$7.95M
Dividends paid
-
-
-
PLSE operating cash flow (10-K history)
Pulse Biosciences, Inc. reported operating cash flow of -$54.12M for fiscal year 2025. That is down 48.9% from -$36.34M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$8.05M (FY 2016) to -$54.12M. Figures come from the company's audited annual reports as filed with the SEC.